Anti-Tumor Effect of a Novel Soluble Recombinant Human Endostatin: Administered as a Single Agent or in Combination with Chemotherapy Agents in Mouse Tumor Models

BACKGROUND: Angiogenesis has become an attractive target in cancer treatment. Endostatin is one of the potent anti-angiogenesis agents. Its recombinant form expressed in the yeast system is currently under clinical trials. Endostatin suppresses tumor formation through the inhibition of blood vessel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Zhihua, Wang, Yanan, Jiang, Wenhong, Dai, Wei, Jiang, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168263/
https://www.ncbi.nlm.nih.gov/pubmed/25229620
http://dx.doi.org/10.1371/journal.pone.0107823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168263/
https://www.ncbi.nlm.nih.gov/pubmed/25229620
http://dx.doi.org/10.1371/journal.pone.0107823

Ejemplares similares